Clinical Trials

Medidata leads as Most Preferred EDC Provider in new report

Medidata Rave EDC ranked No. 1 most recently used EDC system across the industry

Medidata, a Dassault Systèmes company, was rated the pharmaceutical industry’s preferred provider of electronic data capture (EDC) solutions in a new report by Industry Standard Research. This report also identified Medidata’s Rave EDC as the No. 1 most recently used EDC system across the industry.

“We understand that for our customers and their patients, a robust, secure, and flexible EDC system is the cornerstone of a successful clinical trial,” says Wayne Walker, senior vice president, Rave Platform Technology, Medidata. “This recognition reinforces our belief that we have the groundbreaking technological solutions and expertise needed to meet our clients’ evolving needs.”

The EDC Benchmarking and Market Dynamics (5th Ed.) report surveyed 114 respondents on a range of topics, including EDC provider performance, EDC selection criteria, and EDC trends. Respondents from North America, Europe, and Asia selected Rave EDC as the most preferred solution based on the ease of use for sites, sponsors, and contract research organizations (CROs), scalability, real-time data access, capability for mid-study changes, and technical support and training.

Leveraging tools like EDC help set the pace and determine the success of an entire study. Customers are looking for clinical trial technology solutions that are flexible and scalable and provide data confidence as a study progresses. Ultimately, robust EDC benefits patients by accelerating promising drug development and bringing new medicines to market more quickly and efficiently.

Medidata is a pioneer of EDC and a leader in the industry. The Medidata Platform, the company’s unified life sciences platform, which includes Rave EDC, connects patients, sites, sponsors, and partners in a secure and scalable cloud environment to bring life changing treatments to those who need them most.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!

Related posts

Stephanie Ailey Named DM Clinical Research VP of Business Development

PR Newswire

Alimentiv and Satisfai Health announce availability of Certai

PR Newswire

Lotus Clinical Research Announces Expanded Partnership with Veeva

PR Newswire